Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · May 09, 2024

Early Postnatal High-Dose Fat-Soluble Enteral Vitamin A Supplementation to Lower Risk for Moderate or Severe Bronchopulmonary Dysplasia or Death in Infants With Extremely Low Birthweight

The Lancet Respiratory Medicine


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Respiratory Medicine
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trial
Lancet Respir Med 2024 Apr 18;[EPub Ahead of Print], S Meyer, J Bay, AR Franz, H Erhardt, L Klein, J Petzinger, C Binder, S Kirschenhofer, A Stein, B Hüning, A Heep, E Cloppenburg, J Muyimbwa, T Ott, J Sandkötter, N Teig, S Wiegand, M Schroth, A Kick, D Wurm, C Gebauer, K Linnemann, J Kittel, C Wieg, U Kiechl-Kohlendorfer, S Schmidt, R Böttger, W Thomas, F Brevis Nunez, A Stockmann, T Kriebel, A Müller, D Klotz, P Morhart, D Nohr, HK Biesalski, EZ Giannopoulou, S Hilt, M Poryo, S Wagenpfeil, N Haiden, C Ruckes, A Ehrlich, L Gortner

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading